Secondary and Tertiary Hyperparathyroidism

Definitions & Overview (2°/3° HPT) - PTH Party Crashers

• Secondary Hyperparathyroidism (2° HPT):
  • ↑PTH due to chronic hypocalcemia (e.g., CKD, Vit D deficiency).
  • Parathyroid glands: Hyperplastic, reactive.
  • Labs: ↓/Normal $Ca^{2+}$, ↑$PO_4^{3-}$ (CKD), ↑PTH, ↓Vit D.
• Tertiary Hyperparathyroidism (3° HPT):
  • Autonomous PTH secretion after prolonged 2° HPT.
  • Parathyroid glands: Adenomatous, autonomous.
  • Labs: ↑$Ca^{2+}$ (hypercalcemia), markedly ↑PTH.
• Core Difference:
  • 2° HPT: Reactive PTH surge to low $Ca^{2+}$.
  • 3° HPT: Uncontrolled PTH secretion despite normal/high $Ca^{2+}$.

⭐ Tertiary HPT features persistent hypercalcemia & ↑PTH even post-renal transplant, unlike resolving secondary HPT.

Pathophysiology (2°/3° HPT) - Gland Gone Wild

• Secondary HPT (2° HPT):
  • Adaptive response to chronic hypocalcemia, often from Chronic Kidney Disease (CKD).
  • CKD → ↓ active Vit D ($1,25(OH)_2D_3$) & ↑ $PO_4^{3-}$ retention.
  • Leads to: ↓ serum $Ca^{2+}$ & ↑ serum $PO_4^{3-}$.
  • Parathyroid glands undergo diffuse hyperplasia → ↑ PTH secretion to normalize $Ca^{2+}$.
• Tertiary HPT (3° HPT):
  • Develops from long-standing, severe 2° HPT.
  • Parathyroid glands become autonomous (adenomatous or monoclonal hyperplastic change).
  • Persistent, excessive PTH secretion despite correction of hypocalcemia (e.g., post-renal transplant).
  • Results in hypercalcemia.

⭐ In tertiary HPT, one or more parathyroid glands develop autonomous function, leading to hypercalcemia that is no longer responsive to medical management aimed at correcting calcium/phosphate balance.

Clinical Features & Diagnosis (2°/3° HPT) - Spotting the Signs

• Clinical Presentation:

  • 2° HPT: Often asymptomatic; CKD features (fatigue, edema), bone pain, pruritus.
  • 3° HPT: Hypercalcemia symptoms (📌 "bones, stones, groans, moans"), nephrolithiasis.
  • Severe: Renal osteodystrophy (fractures), calciphylaxis (skin necrosis).

• Key Investigations:

  • Laboratory Findings:

    Parameter	Secondary HPT (2°)	Tertiary HPT (3°)
    Serum $Ca^{2+}$	↓ / Normal	↑
    Serum $PO_4^{3-}$	↑	Variable (often ↑)
    ALP	↑	↑
    PTH	↑ (compensatory)	Markedly ↑ (autonomous, >800 pg/mL often)

  • Imaging:
    • X-ray: Osteitis fibrosa cystica (subperiosteal resorption of phalanges, "salt & pepper" skull).
    • Ultrasound/Sestamibi: Gland localization (3° HPT, pre-surgery).

⭐ Autonomous PTH secretion with PTH levels often exceeding 800 pg/mL is characteristic of tertiary hyperparathyroidism.

Management Strategies (2°/3° HPT) - Taming the Glands

• Primary Goal: Normalize serum Ca, P, and PTH levels, preventing complications like bone disease and calciphylaxis.
• Medical Therapy (Foundation for 2° HPT, may be used in 3° HPT):
  • Correct underlying cause (e.g., CKD management, Vit D repletion).
  • Dietary $PO_4^{3-}$ restriction.
  • Phosphate binders (e.g., Sevelamer, Calcium Acetate) to ↓$PO_4^{3-}$ absorption.
  • Active Vitamin D sterols (e.g., Calcitriol, Paricalcitol) to suppress PTH (use cautiously if ↑Ca or ↑$PO_4^{3-}$).
  • Calcimimetics (e.g., Cinacalcet) - ↑CaSR sensitivity, ↓PTH. 📌 "Cina-Calci-Mimics" Ca.

⭐ In tertiary hyperparathyroidism, autonomous parathyroid function persists even after successful renal transplantation; parathyroidectomy is often required for definitive management of hypercalcemia.

High-Yield Points - ⚡ Biggest Takeaways

• Secondary HPT is most often from CKD, causing diffuse parathyroid hyperplasia.
• Labs in Secondary HPT: PTH ↑↑, Ca ↓ or normal, PO₄ ↑ (in CKD).
• Tertiary HPT develops from prolonged secondary HPT (e.g., post-renal transplant) with autonomous PTH secretion.
• A key feature of Tertiary HPT is hypercalcemia (Ca ↑) alongside markedly ↑ PTH.
• Medical management for Secondary HPT includes phosphate binders, Vitamin D analogs, and Cinacalcet.
• Surgery (e.g., subtotal parathyroidectomy) is for refractory secondary or symptomatic tertiary HPT.